Celgene vet Barer lines up a $23M startup round for next-gen I/O tech out of Johns Hopkins
After spending the past year in the hot seat as chairman at a badly dysfunctional Teva, Celgene co-funder Sol Barer can get back to the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
